33% of Type 1 diabetes patients insulin-free with stem cells
A potential stem cell–derived pancreatic islet cell replacement therapy (VX-880, from Vertex Pharmaceuticals) continues to show promise as a treatment for Type 1 diabetes, according
A potential stem cell–derived pancreatic islet cell replacement therapy (VX-880, from Vertex Pharmaceuticals) continues to show promise as a treatment for Type 1 diabetes, according